John Edward Robinson serves as Executive at Cogent Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, John Edward Robinson has executed 4 insider transactions totaling $3.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 26, 2025 involved selling 90,000 shares valued at $3.5M.
John Edward Robinson currently holds 140,002 shares of Cogent Biosciences, Inc. (COGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Edward Robinson has been a net seller of COGT stock. They have purchased $0 and sold $3.5M worth of shares.
John Edward Robinson's most recent insider trade was on Dec 26, 2025, when they sold 90,000 shares at $38.74 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 17, 2025 | COGT | $5.5M | Payment | 139,998 | $39.45 | Discretionary |
| Dec 17, 2025 | COGT | $0 | Award | 50,000 | $N/A | Discretionary |